Andrew Kramar

3, Rue Frederic Combemale
Lille, 59000, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 103 publications

Cervical cancer in French Guiana before the implementation of the University Hospital: Outcome and prognosis.

Cervical cancer in French Guiana before the implementation of the University Hospital: Outcome and prognosis.

Journal: Bulletin du cancer
Published: May 18, 2026

Erratum to: Survival, safety, and prognostic factors for outcome with Regorafenib in patients with metastatic colorectal cancer refractory to standard therapies: results from a multicenter study (REBECCA) nested within a compassionate use program.

Erratum to: Survival, safety, and prognostic factors for outcome with Regorafenib in patients with metastatic colorectal cancer refractory to standard therapies: results from a multicenter study (REBECCA) nested within a compassionate use program.

Journal: BMC cancer
Published: July 13, 2016

A Statistical Approach to Determine the Optimal Duration of Post-Treatment Follow-Up: Application to Metastatic Nonseminomatous Germ Cell Tumors.

A Statistical Approach to Determine the Optimal Duration of Post-Treatment Follow-Up: Application to Metastatic Nonseminomatous Germ Cell Tumors.

Journal: Clinical genitourinary cancer
Published: March 11, 2016

Statistical controversies in clinical research: should schedules of tumor size assessments be changed?

Statistical controversies in clinical research: should schedules of tumor size assessments be changed?

Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: March 02, 2016

Goodness-of-fit test for monotone proportional subdistribution hazards assumptions based on weighted residuals.

Goodness-of-fit test for monotone proportional subdistribution hazards assumptions based on weighted residuals.

Journal: Statistics in medicine
Published: December 17, 2015

Survival, safety, and prognostic factors for outcome with Regorafenib in patients with metastatic colorectal cancer refractory to standard therapies: results from a multicenter study (REBECCA) nested within a compassionate use program.

Survival, safety, and prognostic factors for outcome with Regorafenib in patients with metastatic colorectal cancer refractory to standard therapies: results from a multicenter study (REBECCA) nested within a compassionate use program.

Journal: BMC cancer
Published: October 29, 2015

Brain Metastases in Patients With Germ Cell Tumors: Prognostic Factors and Treatment Options--An Analysis From the Global Germ Cell Cancer Group.

Brain Metastases in Patients With Germ Cell Tumors: Prognostic Factors and Treatment Options--An Analysis From the Global Germ Cell Cancer Group.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: October 14, 2015

Radiation-induced CD8 T-lymphocyte Apoptosis as a Predictor of Breast Fibrosis After Radiotherapy: Results of the Prospective Multicenter French Trial.

Radiation-induced CD8 T-lymphocyte Apoptosis as a Predictor of Breast Fibrosis After Radiotherapy: Results of the Prospective Multicenter French Trial.

Journal: EBioMedicine
Published: September 18, 2015

Preoperative chemoradiation with paclitaxel-carboplatin or with fluorouracil-oxaliplatin-folinic acid (FOLFOX) for resectable esophageal and junctional cancer: the PROTECT-1402, randomized phase 2 trial.

Preoperative chemoradiation with paclitaxel-carboplatin or with fluorouracil-oxaliplatin-folinic acid (FOLFOX) for resectable esophageal and junctional cancer: the PROTECT-1402, randomized phase 2 trial.

Journal: BMC cancer
Published: September 18, 2015

First-Line Chemotherapy for Metastatic Esophageal Squamous Cell Carcinoma: Clinico-Biological Predictors of Disease Control.

First-Line Chemotherapy for Metastatic Esophageal Squamous Cell Carcinoma: Clinico-Biological Predictors of Disease Control.

Journal: Oncology
Published: June 25, 2015

ERCC1 and CYP1B1 polymorphisms as predictors of response to neoadjuvant chemotherapy in estrogen positive breast tumors.

ERCC1 and CYP1B1 polymorphisms as predictors of response to neoadjuvant chemotherapy in estrogen positive breast tumors.

Journal: SpringerPlus
Published: May 19, 2015

Analysis of survival adjusted for quality of life using the Q-TWiST function: Interface in R.

Analysis of survival adjusted for quality of life using the Q-TWiST function: Interface in R.

Journal: Computer methods and programs in biomedicine
Published: May 18, 2015
Showing 1-12 of 103

Last Updated: 09/26/2026